Phase 3 biotech developing targeted therapies for cancer.
Industry: Health Care
First Day Return: +36.7%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 09/06/2019 |
Offer Price | $15.00 |
Price Range $14.00 - $16.00 | |
Offer Shares (mm) | 5.7 |
Deal Size ($mm) | $85 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 10/02/2019 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $85 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Boston, MA, United States |
Founded | 2002 |
Employees at IPO | 14 |
Website www.aprea.com |